The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion. Dev Vct Regulatory News (AADV)

Share Price Information for Albion. Dev Vct (AADV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.00
Bid: 83.50
Ask: 86.50
Change: 1.50 (1.76%)
Spread: 3.00 (3.593%)
Open: 85.00
High: 86.50
Low: 86.50
Prev. Close: 85.00
AADV Live PriceLast checked at -
Albion Development VCT is an Investment Trust

To provide investors with regular dividend income combined with long-term capital growth by investing in a broad portfolio of higher growth businesses with a stronger focus on technology companies across a variety of sectors in UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Development VCT PLC: Interim Management Statement

22 Apr 2020 17:30



Albion Development VCT PLC: Interim Management Statement

Albion Development VCT PLC

Interim Management StatementLEI Code 213800FDDMBD9QLHLB38

IntroductionI present Albion Development VCT PLC (the “Company”)’s interim management statement for the period from 1 January 2020 to 31 March 2020.

Impact of coronavirus (Covid-19) and Net asset valueThe Board has been monitoring the ongoing disruption caused by the coronavirus (Covid-19) pandemic and its current impact on portfolio companies. These are unprecedented times with major uncertainty as to the ongoing economic and societal impact of the coronavirus (Covid-19) pandemic, the extent of which is still unknown.

In light of this, the Company announces its unaudited net asset value (NAV) as at 31 March 2020 of £71.85 million or 77.66 pence per share (excluding treasury shares), which represents a decrease of 5.81 pence per share (7.0 per cent.) since 31 December 2019. This reflects reductions across the portfolio, which is carried at fair value, as a result of market conditions arising from the healthcare pandemic. The Board has reassessed the carrying values of all companies within the portfolio and has reduced those which are affected by the current situation. The portfolio is well diversified and has weightings in sectors that are less badly affected by coronavirus (Covid-19) and many companies within the portfolio are well suited to operating in a remote environment.

The Company will pay a dividend of 2.25 pence per share on 29 May 2020 to shareholders on the register on 11 May 2020. After accounting for the dividend the NAV will be 75.41 pence per share.

Fundraising and share issuesDuring the period from 1 January 2020 to 31 March 2020, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs Prospectus Top Up Offers 2019/20:

DateNumber of shares issuedIssue price per share (including costs of issue)Net proceeds £’000
31 January 20209,034,37784.8p to 85.7p7,549

Share buy-backs

Given the uncertainty on valuations caused by coronavirus (Covid-19) and its impact on financial markets in recent times, the Board agreed to suspend the Company’s buy back operation on 18 March 2020 until such time as the Company could provide an updated valuation as at 31 March 2020 of the portfolio and the Company’s NAV.

With this announcement of the NAV of the Company at 31 March 2020, the Board is pleased to announce the resumption of its share buy-back policy, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. However, the level of share buybacks until the announcement of the Company’s interim results, expected during September 2020 shall be limited to £500,000.

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.

Portfolio

The following investments have been made during the period from 1 January 2020 to 31 March 2020:

New investment£000sActivity
Concirrus Limited575A software provider bringing real-time behavioural data analytics to the marine and transport insurance industries
Credit Kudos Limited287Challenger credit bureau helping lenders optimise and automate their affordability and risk assessments
Total new investments862 

Top ten holdings as at 31 March 2020:

InvestmentCarrying value£’000% of net asset valueActivity
Egress Software Technologies Limited 6,4479.0%Encrypted email & file transfer service provider
Proveca Limited4,6006.4%Reformulation of paediatric medicines
Quantexa Limited 3,0104.2%Network analytics platform to detect financial crime
Radnor House School (TopCo) Limited 2,5473.5%Independent school for children aged 5-18
Chonais River Hydro Limited 2,3393.3%Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands
The Street by Street Solar Programme Limited 2,3273.2%Owns and operates photovoltaic systems on domestic properties in the UK
Regenerco Renewable Energy Limited 1,8942.6%Generator of renewable energy from roof top solar installations
Mirada Medical Limited 1,5442.1%Developer of medical imaging software using Deep Learning
G.Network Communications Limited 1,4792.1%Ultra-fast fibre optic broadband provider in central London
Alto Prodotto Wind Limited1,2421.7%Owns and operates community scale wind energy projects on brownfield sites in the UK

Material events and transactions after the period end

There have been no further significant events or transactions between 1 April 2020 and 22 April 2020 that the Board is aware of which would have had a material impact on the financial position of the Company.

Further informationThe Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this Scheme can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AADV.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website under www.albion.capital/funds/AADV.

Ben Larkin, Chairman

22 April 2020For further information please contact:Albion Capital Group LLP – Tel: 020 7601 1850


Date   Source Headline
11th Sep 20085:27 pmRNSTransaction in Own Shares
9th Sep 20089:52 amRNSDoc re. FSA viewing facility
3rd Sep 20084:32 pmRNSTransaction in Own Shares
29th Aug 20085:02 pmRNSTotal Voting Rights
27th Aug 20086:28 pmRNSInterim Results
31st Jul 20084:43 pmRNSTotal Voting Rights
30th Jun 20085:58 pmRNSTotal Voting Rights
27th Jun 20084:26 pmRNSTransaction in Own Shares
20th Jun 20082:58 pmRNSTransaction in Own Shares
12th Jun 20083:00 pmRNSDirector/PDMR Shareholding
12th Jun 20082:31 pmRNSTransaction in Own Shares
10th Jun 20084:03 pmRNSDirector/PDMR Shareholding-Am
10th Jun 20083:32 pmRNSDirector/PDMR Shareholding
3rd Jun 20082:22 pmRNSDirector/PDMR Shareholding
2nd Jun 200811:45 amRNSDoc re. Sale of Investment -
30th May 20084:41 pmRNSTotal Voting Rights
19th May 200812:09 pmRNSInterim Management Statement
30th Apr 20085:00 pmRNSTotal Voting Rights
30th Apr 20081:14 pmRNSDoc re. Close Period
22nd Apr 20086:10 pmRNSAnnual Information Update
16th Apr 20089:05 amRNSFSA viewing facility
7th Apr 20085:28 pmRNSDoc re. Close Period
7th Apr 20085:22 pmRNSFinal Results - Replacement
7th Apr 20084:55 pmRNSFinal Results
31st Mar 20085:06 pmRNSTotal Voting Rights
29th Feb 20085:26 pmRNSTotal Voting Rights
31st Jan 20084:42 pmRNSTotal Voting Rights
3rd Jan 20084:21 pmRNSTotal Voting Rights
2nd Jan 20085:13 pmRNSDirectorate Change
17th Dec 20075:19 pmRNSTransaction in Own Shares
30th Nov 20075:08 pmRNSTotal Voting Rights
21st Nov 20075:11 pmRNSTransaction in Own Shares
20th Nov 20075:30 pmRNSTransaction in Own Shares
15th Nov 20071:04 pmRNSNet Asset Value(s)
5th Nov 20073:31 pmRNSTransaction in Own Shares
2nd Nov 20071:05 pmRNSDirectorate Change
31st Oct 20074:51 pmRNSTotal Voting Rights
1st Oct 20074:21 pmRNSTotal Voting Rights
28th Sep 20079:55 amRNSTransaction in Own Shares
20th Sep 20075:29 pmRNSTransaction in Own Shares
13th Sep 20075:23 pmRNSTransaction in Own Shares
10th Sep 20075:33 pmRNSTransaction in Own Shares
3rd Sep 20075:20 pmRNSTotal Voting Rights
30th Aug 200712:25 pmRNSInterim Results
1st Aug 20074:36 pmRNSTotal Voting Rights
13th Jul 200710:59 amRNSNet Asset Value(s)
2nd Jul 20071:15 pmRNSDirectorate Change
2nd Jul 200711:35 amRNSTotal Voting Rights
29th Jun 20071:34 pmRNSTransaction in Own Shares
7th Jun 20074:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.